Atlastin GTPases are required for Golgi apparatus and ER morphogenesis.

The hereditary spastic paraplegias (SPG1-33) comprise a cluster of inherited neurological disorders characterized principally by lower extremity spasticity and weakness due to a length-dependent, retrograde axonopathy of corticospinal motor neurons. Mutations in the gene encoding the large oligomeric GTPase atlastin-1 are responsible for SPG3A, a common autosomal dominant hereditary spastic paraplegia. Here we describe a family of human GTPases, atlastin-2 and -3 that are closely related to atlastin-1. Interestingly, while atlastin-1 is predominantly localized to vesicular tubular complexes and cis-Golgi cisternae, mostly in brain, atlastin-2 and -3 are localized to the endoplasmic reticulum (ER) and are most enriched in other tissues. Knockdown of atlastin-2 and -3 levels in HeLa cells using siRNA (small interfering RNA) causes disruption of Golgi morphology, and these Golgi structures remain sensitive to brefeldin A treatment. Interestingly, expression of SPG3A mutant or dominant-negative atlastin proteins lacking GTPase activity causes prominent inhibition of ER reticularization, suggesting a role for atlastin GTPases in the formation of three-way junctions in the ER. However, secretory pathway trafficking as assessed using vesicular stomatitis virus G protein fused to green fluorescent protein (VSVG-GFP) as a reporter was essentially normal in both knockdown and dominant-negative overexpression conditions for all atlastins. Thus, the atlastin family of GTPases functions prominently in both ER and Golgi morphogenesis, but they do not appear to be required generally for anterograde ER-to-Golgi trafficking. Abnormal morphogenesis of the ER and Golgi resulting from mutations in atlastin-1 may ultimately underlie SPG3A by interfering with proper membrane distribution or polarity of the long corticospinal motor neurons.

[1]  Seungbok Lee,et al.  Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila , 2008, Neurobiology of Aging.

[2]  Y. Jan,et al.  Growing Dendrites and Axons Differ in Their Reliance on the Secretory Pathway , 2007, Cell.

[3]  S. Züchner The genetics of hereditary spastic paraplegia and implications for drug therapy , 2007, Expert opinion on pharmacotherapy.

[4]  H. Hauri,et al.  Climp-63-mediated binding of microtubules to the ER affects the lateral mobility of translocon complexes , 2007, Journal of Cell Science.

[5]  C. Blackstone,et al.  Characterization of a novel SPG3A deletion in a French‐Canadian family , 2007, Annals of neurology.

[6]  M. Ruberg,et al.  Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis , 2007, Molecular and Cellular Neuroscience.

[7]  Katia J. Evans,et al.  Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Hauri,et al.  Morphogenesis of the Endoplasmic Reticulum: Beyond Active Membrane Expansion , 2006, Traffic.

[9]  C. Blackstone,et al.  SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. , 2006, Human molecular genetics.

[10]  B. Goud,et al.  Rab1 defines a novel pathway connecting the pre-Golgi intermediate compartment with the cell periphery. , 2006, Molecular biology of the cell.

[11]  J. Luzio,et al.  Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. , 2006, Human molecular genetics.

[12]  M. Ruberg,et al.  SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years , 2006, Neurology.

[13]  C. Blackstone,et al.  Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. , 2006, Pharmacology & therapeutics.

[14]  M. Ruberg,et al.  Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. , 2004, Archives of neurology.

[15]  J. Weissenbach,et al.  Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A , 2004, Neurogenetics.

[16]  C. Blackstone,et al.  Intra- and Intermolecular Domain Interactions of the C-terminal GTPase Effector Domain of the Multimeric Dynamin-like GTPase Drp1* , 2004, Journal of Biological Chemistry.

[17]  P. Bergh,et al.  Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome , 2004, Nature Genetics.

[18]  Harvey T. McMahon,et al.  The dynamin superfamily: universal membrane tubulation and fission molecules? , 2004, Nature Reviews Molecular Cell Biology.

[19]  A. Crosby,et al.  SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia , 2003, Journal of the Neurological Sciences.

[20]  C. Blackstone,et al.  Cellular Localization, Oligomerization, and Membrane Association of the Hereditary Spastic Paraplegia 3A (SPG3A) Protein Atlastin* , 2003, Journal of Biological Chemistry.

[21]  F. Boaretto,et al.  Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation , 2003, Neurology.

[22]  C. Blackstone,et al.  Interaction of the deafness-dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1. , 2003, Biochemical and biophysical research communications.

[23]  E. Reid,et al.  Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias , 2003, Journal of medical genetics.

[24]  A. Crosby,et al.  Is the transportation highway the right road for hereditary spastic paraplegia? , 2002, American journal of human genetics.

[25]  G. Tedeschi,et al.  Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia , 2002, Annals of neurology.

[26]  P. Hedera,et al.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia , 2001, Nature Genetics.

[27]  E. Sztul,et al.  ER to Golgi Transport: Requirement for P115 at a Pre-Golgi Vtc Stage , 1999 .

[28]  K. Kohno,et al.  Conformational changes of the smooth endoplasmic reticulum are facilitated by L‐glutamate and its receptors in rat Purkinje cells , 1998, The Journal of comparative neurology.

[29]  J. Lippincott-Schwartz,et al.  Kinetic Analysis of Secretory Protein Traffic and Characterization of Golgi to Plasma Membrane Transport Intermediates in Living Cells , 1998, The Journal of cell biology.

[30]  J. Burkhardt The role of microtubule-based motor proteins in maintaining the structure and function of the Golgi complex. , 1998, Biochimica et biophysica acta.

[31]  E. Salmon,et al.  Endoplasmic reticulum membrane tubules are distributed by microtubules in living cells using three distinct mechanisms , 1998, Current Biology.

[32]  Robert Presley,et al.  Evolutionary biology: Pelvic problems for mammals , 1997, Nature.

[33]  Jennifer Lippincott-Schwartz,et al.  ER-to-Golgi transport visualized in living cells , 1997, Nature.

[34]  J. Lippincott-Schwartz,et al.  Golgi dispersal during microtubule disruption: regeneration of Golgi stacks at peripheral endoplasmic reticulum exit sites. , 1996, Molecular biology of the cell.

[35]  M. Dailey,et al.  Dynamics of the endoplasmic reticulum and other membranous organelles in growth cones of cultured neurons , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  L. Chen,et al.  Dynamic behavior of endoplasmic reticulum in living cells , 1988, Cell.

[37]  I. Choi,et al.  Hereditary spastic paraplegia. , 1983, Yonsei medical journal.